| Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma (NCT06871007) | St. Petersburg State Pavlov Medical University | 2024-09-01 |
| A Study of Selinexor in Combination With Temozolomide and Anti-PD-1 Antibody in Patients With Relapsed/Refractory Primary Central Nervous System Lymphoma (NCT06556199) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2024-08-31 |
| Venetoclax-Navitoclax With Cladribine-based Salvage Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT06007911) | Medical College of Wisconsin | 2024-08-31 |
| A PhaseⅠ Comparative Study to Evaluate the Pharmacokinetics of QL2108 to Dupixent® (NCT06614907) | Qilu Pharmaceutical Co., Ltd. | 2024-08-31 |
| BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune Diseases (NCT06787989) | iCell Gene Therapeutics | 2024-08-31 |
| A Study of Pomadomide in Combination With Rituximab and Methotrexate for Newly-diagnosed Primary Central Nervous System Lymphoma (NCT06554561) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2024-08-31 |
| A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory POEMS Syndrome (NCT06518876) | Novatim Immune Therapeutics (Zhejiang) Co., Ltd. | 2024-08-31 |
| A Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate Tablets (NCT06680531) | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | 2024-08-31 |
| A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers. (NCT06116136) | Servier Bio-Innovation LLC | 2024-08-31 |
| Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients (NCT06577961) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-08-31 |
| Study With [225Ac]Ac-FL-020 in mCRPC Participants (NCT06492122) | Full-Life Technologies UK Limited | 2024-08-30 |
| A Pharmacokinetic Study to Compare CBD-NE to Epidyolex in Healthy Adult Volunteers Under Both Fed and Fasted Conditions (NCT06578455) | dsm-firmenich Switzerland AG | 2024-08-30 |
| Short-Term Outcome of Medical Vs. Surgical Management Of Chronic Anal Fissure (NCT06617026) | Suez Canal University | 2024-08-30 |
| A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma (NCT06500507) | Qilu Pharmaceutical Co., Ltd. | 2024-08-30 |
| PD-1, LAG-3 and TIM-3 Checkpoint Blockade in DLBCL (NCT06290622) | University of Alabama at Birmingham | 2024-08-30 |
| A Study to Learn How the Medicine Called [14C] PF-06821497 is Taken up Into and Removed From the Body. (NCT06392230) | Pfizer | 2024-08-30 |
| This is a Study to Evaluate the Pharmacokinetics and Safety of IBI362 in Chinese Adolescents With Obesity (NCT06536023) | Innovent Biologics (Suzhou) Co. Ltd. | 2024-08-30 |
| A Study Evulating DA-302168S Tablets in Overweight/Obese Subjects (NCT06541730) | Chendu DIAO Pharmaceutical Group CO., LTD. | 2024-08-30 |
| Assessment of the Remineralization Efficacy of Vitamin D in the Treatment of MIH. In Vitro Study and In Situ Randomized Double-Blind Placebo Clinical Trial. (NCT06515548) | Cairo University | 2024-08-30 |
| Dose-Escalating Study of Pfs230D1 in Combination With R21 in Matrix-M in African Adults (NCT06507605) | Serum Institute of India Pvt. Ltd. | 2024-08-30 |
| Phase 1 Clinical Trial of CordSTEM-ST (NCT06578039) | CHABiotech CO., Ltd | 2024-08-30 |
| A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers (NCT05911828) | Zydus Lifesciences Limited | 2024-08-30 |
| Feasibility of Gadolinium Contrast Reduced Brain MRI: the Potential of Deep Learning (NCT06462924) | DeepMeds | 2024-08-30 |
| A Study to Find Out How Multiple Doses of BIIB091 Affect the Electrical Activity of the Heart in Healthy Participants (NCT06574828) | Biogen | 2024-08-29 |
| Phase 1b/2 Study of Decitabine and Venetoclax in Combination With the Targeted Mutant IDH1 Inhibitor Olutasidenib (NCT06445959) | M.D. Anderson Cancer Center | 2024-08-29 |
| Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fasting Condition (NCT06233097) | Bio-innova Co., Ltd | 2024-08-29 |
| Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASD141 (NCT06235437) | Ascendo Biotechnology Co., Ltd. | 2024-08-29 |
| Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma. (NCT06440057) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2024-08-29 |
| A Trial to Characterize Differences in Blood Levels of Different Lots of Centanafadine QD XR and to Understand the Effect of Food on Blood Levels (NCT07253441) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2024-08-29 |
| Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma (NCT06585527) | Beijing Neurosurgical Institute | 2024-08-29 |
| A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese (NCT06567327) | Pfizer | 2024-08-28 |
| Open-Label Extension Study for Subjects With H1 Antihistamine Refractory Chronic Spontaneous Urticaria Completing Study AK006-001 (NCT06577116) | Allakos Inc. | 2024-08-28 |
| Beta-Hydroxybutyrate Feasibility Treating IBD (NCT06351124) | University of Texas at Austin | 2024-08-28 |
| Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma (NCT06582017) | Nammi Therapeutics Inc | 2024-08-28 |
| First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS) (NCT06351592) | Regeneron Pharmaceuticals | 2024-08-28 |
| A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients (NCT06540391) | Microbiotica Ltd | 2024-08-28 |
| A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations (NCT06412198) | M.D. Anderson Cancer Center | 2024-08-28 |
| Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors (NCT06573294) | Genmab | 2024-08-28 |
| A Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy Participants (NCT06523153) | Invivyd, Inc. | 2024-08-28 |
| Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM) (NCT06562907) | Gilead Sciences | 2024-08-28 |
| Phase Ib/IIa Clinical Study of ACC017 Tablets (NCT06719310) | Jiangsu Aidea Pharmaceutical Group Co., Ltd. | 2024-08-28 |
| First In Human Study of CX-801 in Advanced Solid Tumors (NCT06462794) | CytomX Therapeutics | 2024-08-28 |
| A Study to Investigate the Pharmacokinetics of Midazolam After Repeated Doses of Camizestrant (AZD9833) and to Investigate the Pharmacokinetics of Camizestrant When Administered Alone and in Combination With Carbamazepine in Healthy Post-Menopausal Female Participants (NCT06547164) | AstraZeneca | 2024-08-27 |
| Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371 LAI in Healthy Participants (NCT06558643) | Medicines for Malaria Venture | 2024-08-27 |
| Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION) (NCT06460844) | Ray Therapeutics, Inc. | 2024-08-27 |
| A Study To Characterize Mass Balance Of [14C] HDM1002 in Chinese Healthy Subjects (NCT06576401) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2024-08-27 |
| A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease (NCT06565195) | Prevail Therapeutics | 2024-08-27 |
| A First-in-Patient Clinical Trial of KINE-101 in Patients With Corticosteroid-Refractory CIDP (NCT07343310) | Kine Sciences Co., Ltd. | 2024-08-27 |
| 2321GCCC: CRD3874-SI in Patients With Relapsed/Refractory AML (NCT06626633) | University of Maryland, Baltimore | 2024-08-26 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of ASC30 Tablets and ASC30 Tablets A1 in Participants With Obesity (NCT06680440) | Ascletis Pharma (China) Co., Limited | 2024-08-26 |
| A Study in Healthy Men to Test How BI 1569912 is Processed in the Body (NCT06520553) | Boehringer Ingelheim | 2024-08-26 |
| Using Diaphragm Ultrasonography, Sugammadex Recovers Diaphragmatic Function More Effectively Than Neostigmine. (NCT06982092) | Ain Shams University | 2024-08-26 |
| A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma (NCT06577376) | Shanghai Runshi Pharmaceutical Technology Co., Ltd | 2024-08-26 |
| Drug-Drug Interactions Between TNP-2198 and Midazolam, Clarithromycin (NCT06551623) | TenNor Therapeutics Inc. | 2024-08-26 |
| Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody (The SAMBA Study) (NCT06668727) | Aarhus University Hospital | 2024-08-26 |
| A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese Participants (NCT06581627) | Novo Nordisk A/S | 2024-08-26 |
| A Study of RAY1225 in Participants With Impaired Liver Function (NCT06577415) | Guangdong Raynovent Biotech Co., Ltd | 2024-08-26 |
| Study of Gamma PN3 in the Elderly (NCT06562790) | GPN Vaccines | 2024-08-26 |
| A Study of BL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors (NCT06493864) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-08-26 |
| A Study to Assess the Effect of Voriconazole and Quinidine on the Pharmacokinetics of a Single Dose of Repotrectinib in Healthy Participants (NCT06493409) | Bristol-Myers Squibb | 2024-08-26 |
| Bioequivalence Study of Generic Racecadotril 100 mg Capsules Under Fasting Conditions (NCT06297174) | Pharma Nueva | 2024-08-26 |
| A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers (NCT06345001) | Bayer | 2024-08-26 |
| First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor (NCT07755397) | Jubilant Therapeutics India Limited | 2024-08-26 |
| Bioequivalence Study of Apixaban 5 mg Film-coated Tablets in Healthy Thai Volunteers (NCT06388239) | International Bio service | 2024-08-26 |
| A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Negative Breast Cancer and Other Solid Tumors (NCT06503783) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-08-24 |
| A Study to Learn How Different Amounts of the Study Medicine Danuglipron Are Taken up Into the Blood in Otherwise Healthy Adults With Overweight or Obesity (NCT06568731) | Pfizer | 2024-08-23 |
| Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer (NCT06589609) | BlueSky Immunotherapies GmbH | 2024-08-23 |
| The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset Parkinson's Disease (NCT06608355) | iRegene Therapeutics Co., Ltd. | 2024-08-23 |
| Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study (NCT06647901) | Tang Xiaodong | 2024-08-23 |
| Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors (NCT06352359) | OncoC4, Inc. | 2024-08-23 |
| Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder (NCT06627413) | Intra-Cellular Therapies, Inc. | 2024-08-23 |
| A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy (NCT06362369) | 7 Hills Pharma, LLC | 2024-08-23 |
| Study for Participants With Relapsed/Refractory Non-Hodgkin Lymphoma (NCT06334991) | ImmunityBio, Inc. | 2024-08-23 |
| A Study of LY4100511 (DC-853) Mass Balance and Absolute Bioavailability of LY4100511 in Healthy Male Participants (NCT06627088) | DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company | 2024-08-23 |
| Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma (NCT06433947) | Opna Bio LLC | 2024-08-22 |
| ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR) (NCT06415487) | Acepodia Biotech, Inc. | 2024-08-22 |
| RADIANT: Pre-op Radiation With Abemaciclib and Letrozole (NCT06139107) | Mridula George, MD | 2024-08-22 |
| A Drug-drug Interaction Study of YZJ-1139 Tablets and Ticagrelor Tablets in Healthy Subjects (NCT06671470) | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | 2024-08-22 |
| A Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus (NCT06530849) | Gracell Biotechnologies (Shanghai) Co., Ltd. | 2024-08-22 |
| Ondansetron Use for Preventing Pruritus in Patients Undergoing Cesarean Section (NCT06297499) | Wayne State University | 2024-08-22 |
| A Study to Explore the Effect of SP-624 on Brain Network Analytics in Healthy Adults and Adults With Major Depression (NCT06570369) | Sirtsei Pharmaceuticals, Inc. | 2024-08-22 |
| Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia (NCT06357182) | OHSU Knight Cancer Institute | 2024-08-22 |
| THC Effects on Glucose in Type 2 Diabetes (NCT05322213) | University of California, San Diego | 2024-08-22 |
| TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer (NCT06532812) | Essen Biotech | 2024-08-22 |
| Long-term Safety Trial with NVDX3 (NCT06532253) | Novadip Biosciences | 2024-08-22 |
| A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors (NCT06533059) | Alterome Therapeutics, Inc. | 2024-08-22 |
| Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma (NCT06185751) | Washington University School of Medicine | 2024-08-22 |
| Study of Oral ABBV-932 Capsules to Evaluate Dopamine D2 and D3 Receptor Occupancy in Brain in Adult Healthy Volunteers (NCT06300580) | AbbVie | 2024-08-21 |
| A Double Blind, Randomized, Cross-over Study Examining the Suppression of the Photoparoxysmal EEG Response With NPT 2042 (NCT06525649) | NeuroPro Therapeutics, Inc. | 2024-08-21 |
| A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors (NCT06549816) | Seagen, a wholly owned subsidiary of Pfizer | 2024-08-21 |
| The Effect of Colchicine on Platelet Function Profiles in Patients With Stable Coronary Artery Disease (NCT06567678) | The University of The West Indies | 2024-08-21 |
| A Study to Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's Syndrome (NCT06544642) | Astellas Pharma Global Development, Inc. | 2024-08-21 |
| A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney Function (NCT06559527) | Novo Nordisk A/S | 2024-08-20 |
| TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer (NCT06538012) | Essen Biotech | 2024-08-20 |
| A Study of [177Lu] Lu-PSMA-XT Injection in Patients With Metastatic Prostate Cancer (NCT07096128) | Jinming Zhang | 2024-08-20 |
| A Study to Evaluate AMG 133 Administered Subcutaneously in Participants With Overweight or Obesity (NCT06976372) | Amgen | 2024-08-20 |
| ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer (NCT06460298) | ProDa BioTech, LLC | 2024-08-20 |
| A Study of FT1 in Healthy Adult Volunteers (NCT06610487) | Chongqing Peg-Bio Biopharm Co., Ltd. | 2024-08-20 |
| A Food-Effect, Drug-Drug Interaction, and Pharmacokinetics Study of NX-5948 in Healthy Adult Subjects (NCT06593457) | Nurix Therapeutics, Inc. | 2024-08-20 |
| A Research Study to Evaluate the Safety and Tolerability of SGC001 in Healthy Subjects (NCT07079618) | Beijing Sungen Biomedical Technology Co., Ltd | 2024-08-20 |